| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.1B | $11.4B | $10.5B | $9.6B | $7.2B | $1.3B | $2.2B | $2.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $2.5B | $2.3B | $2.0B | $1.9B | $1.4B | $1.2B | $1.6B | $1.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.4B | $1.3B | $1.2B | $1.2B | $0.6B | $0.0B | $0.8B | $0.8B |
| Net Income | $1.0B | $1.0B | $1.0B | $1.0B | $0.6B | $-0.5B | $0.2B | $0.2B |
| EPS (Basic) | $8.93 | $8.57 | $8.06 | $7.46 | $4.83 | $-3.86 | $1.69 | $1.41 |
| EPS (Diluted) | $8.86 | $8.51 | $7.99 | $7.39 | $4.77 | $-3.86 | $1.67 | $1.39 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.6B | $11.3B | $10.2B | $10.1B | $10.7B | $9.9B | $5.9B | $5.5B |
| Current Assets | $0.9B | $0.8B | $1.0B | $1.2B | $1.9B | $1.1B | $0.9B | $0.6B |
| Cash & Equivalents | $0.2B | $0.2B | $0.4B | $0.4B | $1.2B | $0.8B | $0.5B | $0.1B |
| Total Liabilities | $10.3B | $9.1B | $8.0B | $7.9B | $7.8B | $7.6B | $3.5B | $3.3B |
| Current Liabilities | $2.2B | $2.2B | $1.9B | $1.8B | $1.8B | $1.8B | $1.5B | $1.4B |
| Stockholders' Equity | $2.3B | $2.2B | $2.2B | $2.2B | $2.8B | $2.3B | $2.4B | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | — | — | — | — |
| Investing Cash Flow | $-1.3B | $-1.3B | $-0.6B | $-0.4B | $-0.3B | — | — | — |
| Capital Expenditures | $0.6B | $0.6B | $0.6B | $0.4B | $0.3B | $0.5B | $0.5B | $0.4B |
| Financing Cash Flow | $-0.4B | $-0.5B | $-1.0B | $-1.6B | $-0.5B | — | — | — |